scholarly journals The efficacy and safety of antihistamine therapy in school-age children

2019 ◽  
Vol 16 (1) ◽  
pp. 79-84
Author(s):  
O I Sidorovich

Every year the prevalence of allergic diseases is steadily increasing. Histamine is the main mediator of allergic inflammation. Cetirizine is an effective, selective H1-receptor blocker, and drug of choice in complex treatment of various allergies among adults as well as children.

Author(s):  
O.I. Sidorovich

ТС каждым годом распространенность аллергических заболеваний (АЗ) неуклонно растет. Гистамин - основной медиатор воспаления при аллергии. Цетиризин является эффективным блокатором H1-гистаминовых рецепторов и препаратом выбора в комплексном лечении различных проявлений аллергии как у взрослых, так и у детей.Every year the prevalence of allergic diseases is steadily increasing. Histamine is the main mediator of allergic inflammation. Cetirizine is an effective, selective H1-receptor blocker, and drug of choice in complex treatment of various allergies among adults as well as children.


2020 ◽  
Vol 13 (3) ◽  
pp. 336-342
Author(s):  
Rafał Pawliczak

H1-receptor blockers (including levocetirizine and desloratadine) are employed in treatment of multiple allergic diseases. In this review we deliver data regarding efficacy and safety these two drugs. Moreover, we are comparing their properties. The individualization therapy is a mainstay in allergic disorders treatment.


2014 ◽  
Vol 113 (4) ◽  
pp. 430-439 ◽  
Author(s):  
Luan M. Chu ◽  
Donna C. Rennie ◽  
Donald W. Cockcroft ◽  
P. Pahwa ◽  
J. Dosman ◽  
...  

2018 ◽  
Vol 15 (2) ◽  
pp. 42-47
Author(s):  
E F Glushkova ◽  
N V Shartanova

Levocetirizine is an effective Hj-blocker in complex treatment of various allergic patients. Allergic rhinitis is often part of a systemic allergic inflammation associated with other allergic diseases, therefore systemic antihistamines are the drugs of choice in it’s treatment.


2020 ◽  
Vol 63 (7) ◽  
pp. 278-283 ◽  
Author(s):  
Jihyun Ha ◽  
Seung Won Lee ◽  
Dong Keon Yon

Background: Major questions remain regarding the agestratified trends of allergic diseases and asthma in Korea.Purpose: To identify the estimated recent prevalence and 10- year trends in asthma, allergic rhinitis, and atopic dermatitis among the Korean population from 2008 to 2017.Methods: This nationwide cross-sectional survey (Korean National Health and Nutrition Examination Survey) over 10 years (2008–2017) examined representative samples of the Korean population (n=85,006) including 2,131 infants, 4,352 preschool children, 12,919 school-age children, 44,200 adults, and 21,404 elderly adults.Results: In the 2016 to 2017 population, the estimated prevalence of asthma was 0.9% in infants, 2.3% in preschool children, 4.1% in school-age children, 2.3% in adults, and 4.1% in the elderly. The estimated prevalence of allergic rhinitis was 9.0%, 20.2%, 27.6%, 17.1%, and 6.9%, respectively. The estimated prevalence of atopic dermatitis was 5.9%, 11.3%, 14.6%, 3.9%, and 1.6%, respectively. Ten-year trends revealed a significant decrease in asthma prevalence in infants, preschool children, and the elderly. and in atopic dermatitis prevalence in infants and preschool children (<i>P</i><0.05 for all trends). Furthermore, 10-year trends demonstrated a significant increase in allergic rhinitis prevalence in school-age children, adults, and the elderly, and in atopic dermatitis prevalence in school-age children and the elderly (<i>P</i><0.05 for all trends).Conclusion: These results improve our understanding of the age-stratified epidemiology of allergic diseases in Korea and suggest the need for the development of tailored and precise strategies to prevent allergic diseases in different age groups.


2020 ◽  
Vol 55 (6) ◽  
pp. 1448-1455
Author(s):  
Olga Gorlanova ◽  
Rhea Appenzeller ◽  
Yasmin S. Mahmoud ◽  
Kathryn A. Ramsey ◽  
Jakob Usemann ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document